
Innovent Biologics Inc
HKEX:1801

Intrinsic Value
The intrinsic value of one
Innovent Biologics Inc
stock under the Base Case scenario is
46.9
HKD.
Compared to the current market price of 50.25 HKD,
Innovent Biologics Inc
is
Overvalued by 7%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Innovent Biologics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Innovent Biologics Inc
Balance Sheet Decomposition
Innovent Biologics Inc
Current Assets | 10.3B |
Cash & Short-Term Investments | 7.9B |
Receivables | 1.2B |
Other Current Assets | 1.2B |
Non-Current Assets | 11.3B |
Long-Term Investments | 3.6B |
PP&E | 5.8B |
Intangibles | 1.3B |
Other Non-Current Assets | 627.4m |
Free Cash Flow Analysis
Innovent Biologics Inc
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
Innovent Biologics Inc
Revenue
|
9.4B
CNY
|
Cost of Revenue
|
-1.5B
CNY
|
Gross Profit
|
7.9B
CNY
|
Operating Expenses
|
-8B
CNY
|
Operating Income
|
-89.7m
CNY
|
Other Expenses
|
-4.9m
CNY
|
Net Income
|
-94.6m
CNY
|
Profitability Score
Profitability Due Diligence
Innovent Biologics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Score
Innovent Biologics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Innovent Biologics Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Score
Innovent Biologics Inc's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Innovent Biologics Inc
According to Wall Street analysts, the average 1-year price target for
Innovent Biologics Inc
is 56.51 HKD
with a low forecast of 35.35 HKD and a high forecast of 70.35 HKD.
Dividends
Current shareholder yield for Innovent Biologics Inc is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Innovent Biologics Inc
stock under the Base Case scenario is
46.9
HKD.
Compared to the current market price of 50.25 HKD,
Innovent Biologics Inc
is
Overvalued by 7%.